Thomas L. Long

Corporate Officer/Principal presso PLX PHARMA WINDDOWN CORP.

Health Technology

Profilo

Thomas L.
Long is currently the VP-Manufacturing & Technical Operations at PLx Pharma, Inc. He previously worked as the SVP & General Manager-Manufacturing Operations at Adams Respiratory Therapeutics, Inc.

Posizioni attive di Thomas L. Long

Società	Posizione	Inizio
PLX PHARMA WINDDOWN CORP.	Corporate Officer/Principal	19/09/2017

Tutte le posizioni attive di Thomas L. Long

Precedenti posizioni note di Thomas L. Long

Società	Posizione	Fine
Adams Respiratory Therapeutics, Inc. Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Thomas L. Long

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas L. Long

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Adams Respiratory Therapeutics, Inc. Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ	Health Technology
PLx Pharma, Inc. PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of a technology platform for approved drugs. It offers the PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Dover, DE.	Health Technology